🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for AD

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema) NCT07355075Phase 2, Phase 31 site📍 Irving Turn Therapeutics · Tests: GX-03, Vehicle Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's Disease NCT07294885NA1 site📍 Shenyang General Hospital of Shenyang Military Region · Tests: deep cervical lymphaticovenous anastomosis Daridorexant for Alzheimer Disease Prevention NCT07213349Phase 21 site📍 Montreal Douglas Mental Health University Institute · Tests: Daridorexant 50 mg, Placebo Evaluation of a Neuropsychological Tool to Assess Temporal Processing Abilities in Alzheimer's Disease NCT07341009n/a1 site📍 Caen University Hospital, Caen · Tests: Chronos battery A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD) NCT06657768Phase 113 sites📍 Los Alamitos📍 Lady Lake📍 Maitland Eli Lilly and Company · Tests: LY4006895, Placebo Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD NCT05881239n/a1 site📍 Boston Massachusetts General Hospital · Tests: AROMHA Brain Health Test Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD) NCT05205980NA1 site📍 Valdosta Georgia State University · Tests: Perturbation training COGSCREEN II: Early Detection of Cognitive Impairment NCT07466394NA1 site📍 München Robert Perneczky · Tests: Early Detection Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia NCT06922188n/a1 site📍 Seattle Fred Hutchinson Cancer Center Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis NCT07298395Phase 232 sites📍 Birmingham📍 Hot Springs📍 Beverly Hills Enveda Therapeutics · Tests: ENV-294, Placebo Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers NCT05395624Phase 1, Phase 23 sites📍 San Francisco📍 Stanford📍 Jacksonville Ashvattha Therapeutics, Inc. · Tests: 18F-OP-801 Cognitive Decline in AD NCT03946930n/a1 site📍 Hong Kong Chinese University of Hong Kong NeuroCare Community Project: A Community Based Prospective Observational Study for Early Alzheimer's Detection in HK NCT07347574n/a1 site📍 Hong Kong Hong Kong University of Science and Technology · Tests: Observational Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals NCT02455479Phase 11 site📍 New York Weill Medical College of Cornell University · Tests: dAd5GNE Vaccine, Placebo Levetiracetam for Persons at Risk for Alzheimer's Disease NCT07477431Phase 22 sites📍 Toronto📍 Toronto Sunnybrook Health Sciences Centre · Tests: Levetiracetam (LEV), Placebo Multimodal Assesment of Alzheimer Patients NCT06448403n/a1 site📍 Trondheim Norwegian University of Science and Technology · Tests: MRI Scanning, 64-channel EEG, Polysomnography, Blood samples, Fecal samples Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells NCT06967831n/a2 sites📍 Düsseldorf📍 Berlin Charite University, Berlin, Germany · Tests: skin biopsy, generation of iPSCs, blood drawing, off-label compassionate drug use [18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD NCT06120049Phase 2, Phase 32 sites📍 Ghent📍 Leuven prof. dr. Koen Van Laere · Tests: [18F]-MFBG PET CT, [18F]-FE-PE2I PET CT or PET MRI, [123I]-MIBG SPECT CT, [18F]-MFBG PET dosimetry scans Longitudinal Profiling of Plasma-Derived Glial Extracellular Vesicles in Alzheimer's Disease NCT07803055NA1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: blood sampling A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD) NCT07239947Phase 110 sites📍 Hefei📍 Wuhu📍 Beijing Bambusa Therapeutics · Tests: BBT001, Placebo Music Therapy for Patients With Alzheimer's Disease NCT05151562NA1 site📍 Baltimore Johns Hopkins University · Tests: Virtual Music Therapy Mindfulness to Enhance Cognitive Health in Latino Older Adults NCT07040904NA1 site📍 St Louis Washington University School of Medicine · Tests: mindfulness Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease NCT05795634NA1 site📍 Baltimore Johns Hopkins University · Tests: Trier Social Stress Test Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population NCT07259343NA1 site📍 Aguascalientes Universidad Autónoma de Aguascalientes · Tests: glycomacropeptide, emollient cream Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis NCT07316465NA1 site📍 Jette Universitair Ziekenhuis Brussel · Tests: Development of atopic dermatitis with/without IgE autoantibodies Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease NCT07651319Phase 1, Phase 21 site📍 Houston The Methodist Hospital Research Institute · Tests: IL-2 (Aldesleukin), Semaglutide Plus IL-2, Placebo Brain NAD in Alzheimer's Disease NCT07127510n/a1 site📍 Boca Raton Florida Atlantic University Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis NCT07042126Phase 33 sites📍 Beijing📍 Jinhua📍 Nanchang Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · Tests: 611, Matching placebo Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis NCT06982352Phase 13 sites📍 Fargo📍 Dallas📍 Amman LAPIX Therapeutics Inc. · Tests: LPX-TI641, Placebo A Study of AMDX-2011P in Participants With Alzheimer's Disease NCT06514001Phase 21 site📍 Phoenix Amydis Inc. · Tests: AMDX-2011P
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy